This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objective of this clinical trial is to evaluate the efficacy of IVIG in improving the live birth rate in couples with unexplained recurrent spontaneous abortion (RSA). By evaluating the use of IVIG in this patient population, a greater understanding of the maternal immune response to pregnancy will be achieved.
Showing the most recent 10 out of 185 publications